11th Annual Pharma Anti-Counterfeiting & Serialisation 2023

The 11th Annual Pharma Anti-Counterfeiting & Serialisation 2023 was a pivotal event held on 7-8 February 2023 at the Pestana Chelsea Bridge Hotel in London, UK. Organised by Virtue Insight, this conference focused on combating the global issue of counterfeit pharmaceuticals through advanced serialisation and anti-counterfeiting strategies. It brought together industry leaders, regulatory authorities, and experts to discuss and develop solutions to safeguard the pharmaceutical supply chain.

Key topics covered included the latest advancements in serialisation technologies, track and trace systems, and the implementation of blockchain for enhanced supply chain integrity. Sessions delved into regulatory compliance, particularly concerning the Drug Supply Chain Security Act (DSCSA) and the European Falsified Medicines Directive (FMD), providing insights into global standards and best practices. The conference also addressed the economic and health impacts of counterfeit drugs, emphasizing the need for robust security measures to protect patients and preserve brand integrity.

The event featured a series of keynote presentations and panel discussions from distinguished speakers such as Luis Perez, Country Attache for the UK at the FDA Office of Criminal Investigations; Thomas Welch, Deputy Attache at the London Office of the Department of Homeland Security; and Heather Henson, Senior Director of Investigations and Intelligence at Genentech. Networking opportunities were abundant, allowing attendees to engage with leading international vendors and explore innovative solutions in the co-located exhibition. The conference aimed to foster collaboration and knowledge sharing among stakeholders to strengthen the pharmaceutical industry's response to counterfeiting.

This conference was particularly beneficial for pharmaceutical manufacturers, distributors, regulatory agencies, and technology providers involved in supply chain security. It offered a platform to stay abreast of emerging trends, share experiences, and collaborate on effective strategies to combat counterfeit medicines, thereby ensuring patient safety and maintaining the integrity of the pharmaceutical market.